Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022

SELL
$8.35 - $12.6 $2.75 Million - $4.16 Million
-329,774 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$10.13 - $15.0 $1,124 - $1,665
111 Added 0.03%
329,774 $3.53 Million
Q2 2021

Aug 05, 2021

BUY
$13.27 - $18.48 $194,670 - $271,101
14,670 Added 4.66%
329,663 $5.12 Million
Q1 2021

May 14, 2021

SELL
$14.49 - $20.72 $206,569 - $295,384
-14,256 Reduced 4.33%
314,993 $5.11 Million
Q4 2020

Feb 12, 2021

SELL
$14.61 - $22.14 $148,086 - $224,411
-10,136 Reduced 2.99%
329,249 $6.97 Million
Q3 2020

Nov 13, 2020

SELL
$13.67 - $17.77 $494,607 - $642,954
-36,182 Reduced 9.63%
339,385 $5.03 Million
Q2 2020

Aug 13, 2020

BUY
$10.89 - $21.47 $1.23 Million - $2.43 Million
113,223 Added 43.16%
375,567 $5.53 Million
Q1 2020

May 14, 2020

BUY
$10.23 - $24.56 $101,788 - $244,372
9,950 Added 3.94%
262,344 $3.08 Million
Q4 2019

Feb 12, 2020

BUY
$17.42 - $26.61 $1.54 Million - $2.35 Million
88,339 Added 53.85%
252,394 $5.93 Million
Q3 2019

Nov 13, 2019

BUY
$16.36 - $21.39 $165,530 - $216,424
10,118 Added 6.57%
164,055 $3.04 Million
Q2 2019

Aug 14, 2019

BUY
$16.93 - $26.22 $391,286 - $605,996
23,112 Added 17.67%
153,937 $2.86 Million
Q1 2019

May 14, 2019

SELL
$23.15 - $28.34 $85,678 - $104,886
-3,701 Reduced 2.75%
130,825 $0
Q4 2018

Feb 13, 2019

BUY
$22.03 - $32.01 $50,184 - $72,918
2,278 Added 1.72%
134,526 $3.49 Million
Q3 2018

Nov 02, 2018

BUY
$30.0 - $40.85 $128,880 - $175,491
4,296 Added 3.36%
132,248 $4.19 Million
Q2 2018

Aug 08, 2018

BUY
$26.4 - $42.0 $3.38 Million - $5.37 Million
127,952 New
127,952 $4.97 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $133M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.